Swiss Firm Novartis Stops Hydroxychloroquine Trial For COVID-19 Treatment

Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the...